JUAN FRANCISCO
JIMÉNEZ ALONSO
Investigador en el periodo 2014-2017
JOSÉ LUIS
CALLEJAS RUBIO
PROFESOR ASOCIADO CIENCIAS SALUD
Publicaciones en las que colabora con JOSÉ LUIS CALLEJAS RUBIO (13)
2018
-
Association between perceived level of stress, clinical characteristics and psychopathological symptoms in women with systemic lupus erythematosus
Clinical and Experimental Rheumatology, Vol. 36, Núm. 3, pp. 0434-0441
2014
-
Erratum: Health-related Internet use by lupus patients in southern Spain (Clin Rheumatol DOI: 10.1007/s10067-013-2395-z)
Clinical Rheumatology
-
Health-related Internet use by lupus patients in southern Spain
Clinical Rheumatology, Vol. 33, Núm. 4, pp. 567-573
2010
-
Efficacy of cognitive behavioural therapy for the treatment of chronic stress in patients with lupus erythematosus: A randomized controlled trial
Psychotherapy and Psychosomatics, Vol. 79, Núm. 2, pp. 107-115
2009
-
Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus
Clinical and Experimental Rheumatology
-
Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans
Journal of Clinical Investigation, Vol. 119, Núm. 4, pp. 911-923
-
No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus
Lupus, Vol. 18, Núm. 3, pp. 230-234
-
STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk
Annals of the Rheumatic Diseases, Vol. 68, Núm. 11, pp. 1746-1753
2008
2007
-
Analysis of interleukin-23 receptor (IL23R) gene polymorphisms in systemic lupus erythematosus
Tissue Antigens, Vol. 70, Núm. 3, pp. 233-237
2006
-
Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus
BMC Medical Genetics, Vol. 7
-
Stress as a predictor of cognitive functioning in lupus
Lupus, Vol. 15, Núm. 12, pp. 858-864
2004
-
Intolerancia a la hidroxicloroquina comercializada en España (Dolquine®) en pacientes con patología autoinmune
Revista Clinica Espanola, Vol. 204, Núm. 11, pp. 588-591